Apyx Medical Quick Ratio (APYX) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Apyx Medical Corp  (NASDAQ: APYX)

Apyx Medical's Quick Ratio

APYX's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the second quarter 2026, Quick Ratio deteriorated to 2.95 below Apyx Medical's average Quick Ratio.

Within Medical Equipment & Supplies industry 61 other companies have achieved higher Quick Ratio than Apyx Medical in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 798 to 1127.

Explain Quick Ratio?
How much Cash & cash equivalents APYX´s has?
What are APYX´s Current Liabilities?




APYX Quick Ratio (Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
(Jun 30 2025)
Q2
Y / Y Current Liabilities Change -11.47 % -0.66 % 9.13 % 14.89 % -0.69 %
Y / Y Cash & cash equivalent Change -5.75 % 0.41 % -0 % -10.27 % -10.33 %
Quick Ratio MRQ 2.95 3.3 2.71 2.29 2.77
APYX's Total Ranking # 1127 # 798 # 541 # 907 # 423
Seq. Current Liabilities Change -0.98 % -19.26 % 6.58 % 3.9 % 11.1 %
Seq. Cash & cash equivalent Change -11.3 % -1.9 % 26.28 % -14.22 % -5.51 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 62
Healthcare Sector # 408
Overall Market # 1127


Quick Ratio Statistics
High Average Low
26.57 4.47 0.52
(Dec 31 2019)   (Jun 30 2013)




Financial Statements
Apyx Medical's Current Liabilities $ 9 Millions Visit APYX's Balance sheet
Apyx Medical's Cash & cash equivalent $ 28 Millions Visit APYX's Balance sheet
Source of APYX's Sales Visit APYX's Sales by Geography


Cumulative Apyx Medical's Quick Ratio

APYX's Quick Ratio for the trailling 12 Months

APYX Quick Ratio

(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
(Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 2.79 % 5.61 % 3.09 % -3.94 % -8.77 %
Y / Y Cash & cash equivalent TTM Growth -3.7 % -4.97 % -9.66 % -17.25 % -11.55 %
Quick Ratio TTM 2.79 2.75 2.74 2.81 2.98
Total Ranking TTM # 3738 # 2840 # 2054 # 2894 # 2273
Seq. Current Liabilities TTM Growth -2.84 % -0.15 % 2.34 % 3.53 % -0.18 %
Seq. Cash & cash equivalent TTM Growth -1.44 % 0.11 % -0 % -2.4 % -2.74 %


On the trailing twelve months basis Current Liabilities decreased faster than Apyx Medical's average Cash & cash equivalent, this led to increase in in Apyx Medical's Quick Ratio to 2.79, above APYX average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 195 other companies have achieved higher Quick Ratio than Apyx Medical. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2026 from 2840 to 3738.

Explain Quick Ratio?
How much Cash & cash equivalents APYX´s has?
What are APYX´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 196
Healthcare Sector # 873
Within the Market # 3738


trailing twelve months Quick Ratio Statistics
High Average Low
6.02 2.63 0.97
(Mar 31 2020)   (Sep 30 2013)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Biolife Solutions Inc   8.11 $ 113.100  Millions$ 13.947  Millions
Bone Biologics Corporation  7.87 $ 4.032  Millions$ 0.512  Millions
Beyond Air Inc   7.68 $ 26.340  Millions$ 3.428  Millions
Talkspace Inc   7.62 $ 90.998  Millions$ 11.937  Millions
Safe Pro Group Inc   7.24 $ 10.231  Millions$ 1.413  Millions
Delcath Systems Inc   7.22 $ 95.902  Millions$ 13.279  Millions
Streamex Corp   7.16 $ 18.586  Millions$ 2.595  Millions
Endra Life Sciences Inc  7.04 $ 5.540  Millions$ 0.787  Millions
Iradimed Corporation  6.45 $ 59.080  Millions$ 9.164  Millions
Orasure Technologies Inc  6.39 $ 160.582  Millions$ 25.119  Millions
Alpha Pro Tech Ltd   5.94 $ 18.901  Millions$ 3.180  Millions
Si bone inc   5.89 $ 141.519  Millions$ 24.042  Millions
Dexcom Inc   5.84 $ 1,107.000  Millions$ 189.500  Millions
Cvrx inc   5.78 $ 64.586  Millions$ 11.177  Millions
Carlsmed Inc   5.67 $ 70.244  Millions$ 12.397  Millions
Profound Medical Corp   5.24 $ 38.271  Millions$ 7.304  Millions
Rxsight Inc   5.03 $ 404.247  Millions$ 80.444  Millions
Transmedics Group Inc   4.81 $ 472.675  Millions$ 98.283  Millions
Aethlon Medical Inc   4.76 $ 4.934  Millions$ 1.036  Millions
Bluejay Diagnostics Inc  4.53 $ 9.599  Millions$ 2.117  Millions
Hyperfine Inc   4.51 $ 43.458  Millions$ 9.629  Millions
Innovative Eyewear Inc   4.36 $ 2.455  Millions$ 0.563  Millions
Autonomix Medical Inc   4.23 $ 3.460  Millions$ 0.818  Millions
Sharps Technology Inc   4.16 $ 12.071  Millions$ 2.903  Millions
Trisalus Life Sciences Inc   4.14 $ 46.288  Millions$ 11.172  Millions
Kestra Medical Technologies Ltd   4.12 $ 198.911  Millions$ 48.269  Millions
Sight Sciences Inc   3.89 $ 79.753  Millions$ 20.499  Millions
Irhythm Holdings Inc   3.82 $ 839.951  Millions$ 219.981  Millions
Nutriband Inc   3.77 $ 3.422  Millions$ 0.907  Millions
Logicmark Inc  3.71 $ 6.596  Millions$ 1.779  Millions

Date modified: 2026-09-26T07:04:03+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.